BioGend Therapeutics Co., Ltd. (6733)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
25. 70
-0.25
-0.9634%
NT$
4.5B Market Cap
- P/E Ratio
- Div Yield
57,419 Volume
- Eps
NT$ 25.95
Previous Close Want to track 6733 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BioGend Therapeutics Co., Ltd. (6733) Statistics
Valuation metrics
Market Cap 4.5B
Enterprise value 3.05B
Trailing P/E (ttm) -49.65
Forward P/E -
PEG ratio -0.61
Price/Sales (ttm) 15.68
Price/Book (mrq) 3.06
Enterprise Value/Revenue 13.25
Enterprise Value/EBITDA -59.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 290.78K
Average volume (90 days) 224.91K
Price summary
52-Week low 23.45
52-Week high 49.15
Beta -
50-Day moving average 25.35
200-Day moving average 30.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,013:1,000
Last split Date 21 Dec 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.3%
Operating margin -0.39%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 34.37%
Book value per share (mrq) 8.96
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
